Overview

This trial is active, not recruiting.

Conditions substance abuse, substance dependence, substance, addiction, alcohol abuse
Treatment linkage patient activation intervention
Sponsor University of California, San Francisco
Collaborator Kaiser Foundation Research Institute
Start date March 2011
End date June 2016
Trial size 504 participants
Trial identifier NCT01621711, 10-01606

Summary

This component of a larger Center of Research Excellence Grant improves treatment for drug abuse by developing effective linkages between specialty drug treatment and primary health care.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking open label
Primary purpose health services research
Arm
(No Intervention)
Usual CD treatment, including therapy groups and individual counseling sessions, and six 45-min medical education groups. Physician appointments, pharmacotherapy, and SUD medications were be available as needed.
(Experimental)
Usual Care with the exception that the six 45-min Linkage patient activation education groups replaced the six 45-min Usual Care medical education groups, plus a linkage phone call (and/or a facilitated email) with the patient, clinician, and Primary Care physician.
linkage patient activation intervention
Usual Care plus Linkage encompassed Usual Care with the exception that the six 45-min Linkage patient activation education groups replaced the six 45-min Usual Care medical education groups, plus a linkage phone call (and/or a facilitated email) with the patient, clinician, and Primary Care physician. The patient activation intervention components -- 1) six 45-min Linkage sessions on activation regarding overall health behaviors and 2) a linkage phone call (and/or a facilitated email) with the patient, clinician, and PC physician -- were delivered by a clinical psychologist.

Primary Outcomes

Measure
patient activation measure
time frame: 6 months post baseline
patient engagement in health care (including patient portal use, familiarity and satisfaction with Primary Care physician, and CD treatment length of stay)
time frame: 6 months post baseline
Substance use and mental health outcomes
time frame: 6 months post baseline

Secondary Outcomes

Measure
patient activation measure at 12 and 24 months
time frame: 12 and 24 months post baseline
patient engagement in health care at 12 and 24 months
time frame: 12 and 24 months post baseline
Substance use and mental health outcomes at 12 and 24 months
time frame: 12 and 24 months post baseline
Health care utilization and cost
time frame: 12 and 24 months post baseline

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Research participants will be adult patients at the Kaiser Permanente San Francisco Chemical Dependency Recovery Program, who have completed 2 weeks of treatment. Exclusion Criteria: - Patients with a diagnosis of dementia, mental retardation, or who are actively psychotic or suicidal will be excluded by their clinician.

Additional Information

Official title Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care
Principal investigator Constance M Weisner, DrPH, LCSW
Description This is a longitudinal two-arm quasi-experimental 3-month alternating off/on design over a 30 month period in which, after a random start, the Linkage condition alternately is added to Usual Care in the Chemical Dependency (CD) clinic and then removed. We compare Usual Care to Usual Care plus Linkage. Follow-up interviews will be conducted at 6, 12 and 24 months. The Linkage intervention includes Usual Care plus 1) sessions on activation regarding overall health behaviors and on selecting a Primary Care physician and communicating with him/her, and 2) a linkage phone call (and/or a facilitated email) with the patient, clinician, and Primary Care physician. The intervention aims to place drug abuse problems in the context of overall health and health care and to activate patients to increase involvement in their own health care.
Trial information was received from ClinicalTrials.gov and was last updated in October 2015.
Information provided to ClinicalTrials.gov by University of California, San Francisco.